Financial reports
ARS
2023 FY
Annual report to shareholders
20 Mar 24
10-K/A
2023 FY
Annual report (amended)
21 Feb 24
10-K
2023 FY
Annual report
20 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
22 Mar 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
Current reports
8-K
Boston Scientific Announces Results for First Quarter 2024
24 Apr 24
8-K
Other Events
4 Apr 24
8-K
Entry into a Material Definitive Agreement
27 Feb 24
8-K
Departure of Directors or Certain Officers
31 Jan 24
8-K
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
31 Jan 24
8-K
Entry into a Material Definitive Agreement
8 Jan 24
8-K
Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction
8 Jan 24
8-K
Departure of Directors or Certain Officers
22 Nov 23
8-K
Boston Scientific Announces Results for Third Quarter 2023
26 Oct 23
8-K
Boston Scientific Announces Results for Second Quarter 2023
27 Jul 23
Registration and prospectus
424B2
Prospectus for primary offering
23 Feb 24
FWP
Free writing prospectus
22 Feb 24
424B5
Prospectus supplement for primary offering
22 Feb 24
25-NSE
Exchange delisting
1 Jun 23
S-8
Registration of securities for employees
6 May 22
424B2
Prospectus for primary offering
4 Mar 22
FWP
Free writing prospectus
3 Mar 22
424B5
Prospectus supplement for primary offering
3 Mar 22
S-3ASR
Automatic shelf registration
23 Feb 22
S-8
Registration of securities for employees
5 Aug 20
Proxies
DEFA14A
Additional proxy soliciting materials
20 Mar 24
DEF 14A
Definitive proxy
20 Mar 24
PRE 14A
Preliminary proxy
7 Mar 24
DEFR14A
Revised proxy
22 Mar 23
DEFA14A
Additional proxy soliciting materials
22 Mar 23
DEF 14A
Definitive proxy
22 Mar 23
DEFA14A
Additional proxy soliciting materials
23 Mar 22
DEF 14A
Definitive proxy
23 Mar 22
DEFA14A
Additional proxy soliciting materials
24 Mar 21
DEF 14A
Definitive proxy
24 Mar 21
Other
SD
Conflict minerals disclosure
25 May 23
SD
Conflict minerals disclosure
25 May 22
SD
Conflict minerals disclosure
19 May 21
SD
Conflict minerals disclosure
28 May 20
CERT
Certification of approval for exchange listing
28 May 20
CERT
Certification of approval for exchange listing
13 Nov 19
SD
Conflict minerals disclosure
29 May 19
SD
Conflict minerals disclosure
30 May 18
SD
Conflict minerals disclosure
15 May 17
UPLOAD
Letter from SEC
13 Dec 16
Ownership
4
John Bradley Sorenson
2 Apr 24
4
Wendy Carruthers
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Jeffrey B. Mirviss
19 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
4/A
Eric Francis Yves Thepaut
11 Mar 24
4
Emily Woodworth
5 Mar 24
3
Emily Woodworth
5 Mar 24
4
Wendy Carruthers
4 Mar 24